# A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension

> **NCT07113392** · PHASE3 · NOT_YET_RECRUITING · sponsor: **Jiangxi Kvvit Pharmaceutical Co., Ltd.** · enrollment: 144 (estimated)

## Conditions studied

- Influenza

## Interventions

- **DRUG:** Suraxavir Marboxil
- **DRUG:** Oseltamivir

## Key facts

- **NCT ID:** NCT07113392
- **Lead sponsor:** Jiangxi Kvvit Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2025-08-01
- **Primary completion:** 2026-08-01
- **Final completion:** 2026-08-01
- **Target enrollment:** 144 (ESTIMATED)
- **Last updated:** 2025-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07113392

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07113392, "A Study to Evaluate the Safety, Efficacy and Pharmacokinetics of Suraxavir Marboxil for Suspension". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT07113392. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*